About Sunways
Sunways is a company based in Mumbai (India) founded in 1951. Sunways has raised $15 million across 1 funding round from investors including InvAscent. Sunways has completed 2 acquisitions, including Inor Medical Products and Inor Orthopaedics. Sunways offers products and services including Ophthal Products, ENT Products, and Medical Devices. Sunways operates in a competitive market with competitors including Annexon, Aldeyra, Lyra Therapeutics, Nicox and Decibel Therapeutics, among others.
- Headquarter Mumbai, India
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sunways India Pvt Ltd
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$12.2 M (USD)29.33as on Mar 31, 2022
-
Net Profit
$1.96 M (USD)31.69as on Mar 31, 2022
-
EBITDA
$2.45 M (USD)10.75as on Mar 31, 2022
-
Total Equity Funding
$15 M (USD)
in 1 rounds
-
Latest Funding Round
$15 M (USD), Series B
Oct 21, 2022
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Inor Medical Products
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sunways
Sunways offers a comprehensive portfolio of products and services, including Ophthal Products, ENT Products, and Medical Devices.
Products for eye treatment and care, including drops and ointments
Items for ENT care and treatment
Devices supporting medical applications in eyecare and ENT
People of Sunways
Unlock access to complete
Unlock access to complete
Funding Insights of Sunways
Sunways has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sunways
Sunways has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include InvAscent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on life sciences investments in India.
|
Locked | Locked | Locked |
Investor details for Sunways
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sunways
Sunways has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Inor Medical Products and Inor Orthopaedics.
Investment portfolio details for Sunways
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Orthopedic products and ophthalmic instruments are manufactured.
|
Locked | Locked | 2021 | Locked | |
|
Orthopedic devices are manufactured by Inor Orthopaedics in India.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Sunways
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sunways
Detailed financials for Sunways
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sunways Comparisons
Peer comparison for Sunways
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sunways
Sunways operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Aldeyra, Lyra Therapeutics, Nicox and Decibel Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| Locked | Locked | Locked |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ENT diseases are developed.
|
|
| Locked | Locked | Locked |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| Locked | Locked | Locked |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| Locked | Locked | Locked |
Mobile SDK developed for app engagement and monetization strategies.
|
Detailed competitors of Sunways
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sunways
Complete news archive for Sunways
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunways
Sunways was founded in 1951 and raised its 1st funding round 71 years after it was founded.
Sunways is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sunways is a funded company, having raised a total of $15M across 1 funding round to date.
Annual revenue of Sunways is $12.2M as on Mar 31, 2022.
Sunways was founded in 1951 and is based in Mumbai, India. Ophthalmic and ENT products are manufactured, alongside medical devices. Eye drops and ointments are supplied to support healthcare applications. Medical education programs are backed by the company. Operations emphasize expansion into additional therapeutic areas to meet evolving healthcare requirements in the sector.
Sunways's top competitors include Annexon, Decibel Therapeutics and Alimera Sciences.
Sunways offers Ophthal Products, ENT Products, and Medical Devices.
Sunways has made 2 acquisitions, including Inor Medical Products, and Inor Orthopaedics.
Sunways has 1 investor. Key investors include InvAscent.
The valuation of Sunways is $41.86M as of Oct 2022.